Seth V. Hetherington
Director/Board Member at Apie Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ken Bate | M | 73 | 10 years | |
| Ashwin Datt | M | - |
Apie Therapeutics, Inc.
 Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | 1 years |
| Peter C. Johnson | M | - |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | - |
| Maureen O'Connor | F | - |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | 4 years |
| Diane Jorkasky | M | 72 |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | 3 years |
| Vinay Tannan | M | - |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Morrow | M | 72 |
Glaxo Wellcome, Inc.
| 9 years |
| Timothy Proctor | M | 74 |
Glaxo Wellcome, Inc.
| 6 years |
| Robert Alexander Ingram | M | 81 |
Glaxo Wellcome, Inc.
| 2 years |
| Jonathan Michael Poole | M | 49 | 4 years | |
| Kevin Bitterman | M | 47 | 11 years | |
| Katrine Bosley | F | 56 | - | |
| Stephen Hoffman | M | 70 | 7 years | |
| Michael Higgins | M | 61 | - | |
| David Sinclair | M | - | 5 years | |
| Ronald Cooper | M | 61 | 5 years | |
| Howard Mayer | M | 61 | 3 years | |
| Robert Farrell | M | 58 | 6 years | |
| Simeon George | M | 47 | 5 years | |
| Iain Dukes | M | 65 |
Glaxo Wellcome, Inc.
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 17 years |
| David Savello | M | 78 |
Glaxo Wellcome, Inc.
| 12 years |
| Marc L. Preminger | M | 74 |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 9 years |
| A. Keith Willard | M | 83 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 7 years |
| Tadataka Yamada | M | 78 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 6 years |
| James Anthony Ermilio | M | 61 |
Glaxo Wellcome, Inc.
| 5 years |
| Jeff Brown | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 8 years |
| Timothy J. Williams | M | 69 |
Glaxo Wellcome, Inc.
| 6 years |
| Richard Ernest Gilbert | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 12 years |
| John Bishop | M | 62 | 1 years | |
| Reijo Juhani Salonen | M | 68 |
Glaxo Wellcome, Inc.
| 6 years |
| Pamela Carroll | M | - | 4 years | |
| Michael E. Markels | M | - |
Glaxo Wellcome, Inc.
| 11 years |
| Eric Lefebvre | M | 60 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 2 years |
| Michael W. Heslop | M | 65 |
Glaxo Wellcome, Inc.
| 2 years |
| Trond K. Waerness | M | 56 |
Glaxo Wellcome, Inc.
| 1 years |
| Ravichandran Venkataramani | M | 51 | - | |
| Patrick Gan | M | 66 |
Glaxo Wellcome, Inc.
| 2 years |
| William Williams | M | 68 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 5 years |
| Michel Cimon | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 10 years |
| William L. Hodges | M | 69 |
Glaxo Wellcome, Inc.
| - |
| Gordon Munro | M | 77 |
Glaxo Wellcome, Inc.
| 27 years |
| Nenad Sarapa | M | - |
Glaxo Wellcome, Inc.
| 4 years |
| Thomas Bures | M | 49 | 2 years | |
| Ravichandran Rao | M | - | 3 years | |
| Thomas Heineman | M | - | 4 years | |
| George Esgro | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 13 years |
| Stan Chamberlain | M | - |
Glaxo Wellcome, Inc.
| 6 years |
| Peter J. Azzarello | M | 53 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 8 years |
| Anna M. Seal | F | 67 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 11 years |
| Rick S. Kent | M | 74 |
Glaxo Wellcome, Inc.
| 3 years |
| Adeoye Olukotun | M | 79 |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | - |
| Edward P. Gray | M | 74 |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | 8 years |
| Evan S. Melrose | M | 54 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 3 years |
| Asish Xavier | M | - | 4 years | |
| Michael V. Milburn | M | - |
Glaxo Wellcome, Inc.
| 10 years |
| Ed Mathers Mathers | M | 64 |
Glaxo Wellcome, Inc.
| 3 years |
| Russell Greig | M | 71 | 2 years | |
| Robert A. Hamm | M | 72 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 4 years |
| George Abercrombie | M | 69 |
Glaxo Wellcome, Inc.
| 8 years |
| William James Alexander | M | 74 |
Glaxo Wellcome, Inc.
| 2 years |
| Lucy G. Martindale | F | 69 |
Glaxo Wellcome, Inc.
| 17 years |
| Adrian N. Hobden | M | 71 |
Glaxo Wellcome, Inc.
| - |
| Peter Young | M | 74 |
Glaxo Wellcome, Inc.
| 10 years |
| Eric S. Hoffman | M | 54 | 4 years | |
| Alan Mark Rauch | M | 74 |
Glaxo Wellcome, Inc.
| 7 years |
| Armando Anido | M | 66 |
Glaxo Wellcome, Inc.
| 4 years |
| Michael H. Golden | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 9 years |
| John Didsbury | M | 68 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 7 years |
| Gene Dewhurst Dewhurst | M | 77 |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | - |
| Adonella Aletti | M | - |
Glaxo Wellcome, Inc.
| 2 years |
| Jim Datin | M | 61 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 2 years |
| David W Miller | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 60 | 83.33% |
| Canada | 13 | 18.06% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Seth V. Hetherington
- Personal Network
